Subject(s)
Breast Neoplasms, Male/therapy , Breast Neoplasms/diagnosis , Early Detection of Cancer/standards , Medical Oncology/standards , Societies, Medical/standards , Aftercare/methods , Aftercare/standards , Breast Neoplasms/mortality , Breast Neoplasms/therapy , Breast Neoplasms, Male/diagnosis , Breast Neoplasms, Male/mortality , Early Detection of Cancer/methods , Europe , European Union , Female , Humans , Incidence , Male , Medical Oncology/methods , Patient Care Team/standards , Risk FactorsSubject(s)
Breast Neoplasms/therapy , Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Combined Modality Therapy , Female , Humans , Inflammatory Breast Neoplasms/metabolism , Inflammatory Breast Neoplasms/pathology , Inflammatory Breast Neoplasms/therapy , Neoplasm Metastasis , Neoplasm Staging , Palliative Care/methods , Quality of Life , Receptor, ErbB-2/metabolism , Receptors, Estrogen/metabolismSubject(s)
Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Early Detection of Cancer/methods , Mastectomy, Segmental/methods , Aging , BRCA1 Protein/genetics , BRCA2 Protein/genetics , Biomarkers, Tumor/metabolism , Breast Neoplasms/epidemiology , Breast Neoplasms, Male/epidemiology , Carcinoma in Situ/diagnosis , Carcinoma in Situ/epidemiology , Carcinoma in Situ/therapy , Chemotherapy, Adjuvant , Europe/epidemiology , Female , Follow-Up Studies , Humans , Ki-67 Antigen/metabolism , Lymphatic Metastasis/diagnosis , Male , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Radiotherapy, Adjuvant , Receptor, ErbB-2/metabolism , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Risk AssessmentSubject(s)
Bone Neoplasms/diagnosis , Brain Neoplasms/diagnosis , Breast Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Antineoplastic Agents/therapeutic use , Bone Neoplasms/secondary , Bone Neoplasms/therapy , Brain Neoplasms/secondary , Brain Neoplasms/therapy , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Combined Modality Therapy , Disease Management , Female , Humans , Molecular Targeted Therapy , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Palliative CareABSTRACT
The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the management of this disease were developed. This manuscript summarizes these international consensus guidelines.
Subject(s)
Breast Neoplasms/therapy , Practice Guidelines as Topic , Adaptation, Psychological , Antineoplastic Agents , Antineoplastic Combined Chemotherapy Protocols , Breast Neoplasms/prevention & control , Female , Humans , International Cooperation , Male , Neoplasm Staging , Portugal , Quality of Life , Women's HealthSubject(s)
Breast Neoplasms , Age Factors , Biomedical Research , Breast Neoplasms/diagnosis , Breast Neoplasms/therapy , Europe , Female , Germany , Humans , Risk Assessment , Risk FactorsSubject(s)
Breast Neoplasms/therapy , Organizations , Patient Advocacy , Europe , Female , Health Services Accessibility , Humans , International Cooperation , Internet , Publishing , Women's Health , Women's RightsABSTRACT
EUROPA DONNA, a non-profit-making organisation, is a pan-European movement against breast cancer; it is a coalition that is active in 29 countries, each organised into national independent Fora. In each Forum, a postal survey was conducted between 2001 and 2002. A standardised questionnaire was used to collect information about Forum characteristics and activities, and perceptions of the adequacy of the local health service in relation to the prevention, diagnosis and treatment of breast cancer. Twenty-seven Fora (93%) participated in the survey. The results show the heterogeneity between the Fora in the services offered and activities in the different countries. The Fora also perceived a range of deficiencies in the prevention, diagnosis and treatment of breast cancer within their national health systems. These results highlight the importance of a coalition to establish a consensus among the Fora, and the need for coordinated initiatives in different European countries.
